Download PDF
CC BY-NC-ND 4.0 · Arq Neuropsiquiatr 2016; 74(02): 117-121
DOI: 10.1590/0004-282X20160008
ARTICLE

Speech disorders did not correlate with age at onset of Parkinson’s disease

Distúrbios da fala não se correlacionam com a idade de início da doença de Parkinson
Alice Estevo Dias
Universidade de São Paulo, Faculdade de Medicina, Departamento de Neurologia, Sao Paulo SP, Brasil.
,
Maira Tonidandel Barbosa
Universidade de São Paulo, Faculdade de Medicina, Departamento de Neurologia, Sao Paulo SP, Brasil.
,
João Carlos Papaterra Limongi
Universidade de São Paulo, Faculdade de Medicina, Departamento de Neurologia, Sao Paulo SP, Brasil.
,
Egberto Reis Barbosa
Universidade de São Paulo, Faculdade de Medicina, Departamento de Neurologia, Sao Paulo SP, Brasil.
› Author AffiliationsSupport: National Council of Technological and Scientific Development - Process 141716/03-7.
› Further Information
Also available at
   Permissions and Reprints

ABSTRACT

Speech disorders are common manifestations of Parkinson´s disease.

Objective To compare speech articulation in patients according to age at onset of the disease.

Methods Fifty patients was divided into two groups: Group I consisted of 30 patients with age at onset between 40 and 55 years; Group II consisted of 20 patients with age at onset after 65 years. All patients were evaluated based on the Unified Parkinson’s Disease Rating Scale scores, Hoehn and Yahr scale and speech evaluation by perceptual and acoustical analysis.

Results There was no statistically significant difference between the two groups regarding neurological involvement and speech characteristics. Correlation analysis indicated differences in speech articulation in relation to staging and axial scores of rigidity and bradykinesia for middle and late-onset.

Conclusions Impairment of speech articulation did not correlate with age at onset of disease, but was positively related with disease duration and higher scores in both groups.

RESUMO

Distúrbios da fala são comuns da doença de Parkinson.

Objetivo Comparar a articulação da fala de acordo com a idade de início da doença.

Métodos Cinquenta pacientes foram divididos em dois grupos: Grupo I consistiu de 30 pacientes com idade de início entre 40 e 55 anos; Grupo II foi composto por 20 pacientes com idade de início após os 65 anos. Todos foram avaliados pela Unified Parkinson’s Disease Rating Scale, Hoehn and Yahr e análise perceptual e acústica da fala.

Resultados Não houve diferença estatística significativa entre os dois grupos quanto às características neurológicas e de fala. Análises de correlação indicaram diferença estatística significativa entre articulação da fala, estágio da doença e escores axiais, de rigidez e bradicinesia.

Conclusões A articulação da fala não se correlacionou com a idade de início da doença, mas foi positivamente relacionada à duração da doença e aos escores mais elevados nos dois grupos.

Parkinson´s disease - speech articulation - dysarthria
doença de Parkinson - articulação da fala - disartria

Support: National Council of Technological and Scientific Development - Process 141716/03-7.




Publication History

Received: 07 May 2015

Accepted: 30 September 2015

Article published online:
06 September 2023

© 2023. Academia Brasileira de Neurologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • References

  • 1 Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006;5(6):525-35. doi:10.1016/S1474-4422(06)70471-9
  • 2 Redgrave P, Rodriguez M, Smith Y, Rodriguez-Oroz MC, Lehericy S, Bergman H et al. Goal-directed and habitual control in the basal ganglia: implications for Parkinson’s disease. Nat Rev Neurosci. 2010;11(11):760-72. doi:10.1038/nrn2915
  • 3 Duffy JR. Motor speech disorders: substrates, differential diagnosis and management. 3rd ed. St Louis: Elsevier, 2013. p. 165-89.
  • 4 Ho A, Iansek R, Marigliani C, Bradshaw JL, Gates S. Speech impairment in a large sample of people with Parkinson’s disease. Behav Neurol. 1999;11(3):131-7. doi:10.1155/1999/327643
  • 5 Miller N, Noble E, Jones D, Burn D. Life with communication changes in Parkinson’s disease. Age Ageing. 2006;35(3):235-9. doi:10.1093/ageing/afj053
  • 6 Spencer KA, Rogers MA. Speech motor programming in hypokinetic and ataxic dysarthria. Brain Lang. 2005;94(3):347-66. doi:10.1016/j.bandl.2005.01.008
  • 7 Ho A, Iansek R. Bradshaw JL. Motor instability in Parkinsonian speech intensity. Neuropsychiatry Neuropsychol Behav Neurol. 2001;14(2):109-16.
  • 8 Baumgartner CA, Sapir S, Ramig LO. Voice quality changes following phonatory-respiratory effort treatment (LSVTÒ) versus respiratory effort treatment for people with Parkinson disease. J Voice. 2001;15(1):105-14. doi:10.1016/S0892-1997(01)00010-8
  • 9 Forrest K, Weismer G, Turner G. Kinematic, acoustic and perceptual analysis of connected speech produced by Parkinsonian and normal geriatric adults. J Acoust Soc Am. 1989;85(6):2608-22. doi:10.1121/1.397755
  • 10 Sapir S, Spielman J, Ramig LO, Story BH, Fox C.. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT] on vowel articulation in dysarthric individuals with idiopatic Parkinson’s disease: acoustic and perceptual findings. J Speech Lang Hear Res. 2007;50(4):899-912. doi:10.1044/1092-4388(2007/064)
  • 11 Robertson LT, Hammerstad JP. Jaw movement dysfunction related to Parkinson’s disease and partially modified by levodopa. J Neurol Neurosurg. Psychiatry 1996;60(1):41-50. doi:10.1136/jnnp.60.1.41
  • 12 Ackermann H, Hertrich I, Hehr T. Oral diadochokinesis in neurological dysarthrias. Folia Phoniatr Logop. 1995;47(1):15-23. doi:10.1159/000266338
  • 13 Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K. Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res. 2004;318(1):121-34. doi:10.1007/s00441-004-0956-9
  • 14 Schrag A, Hovris A, Morley D, Quinn N, Jahanshari M. Young-versus older-onset Parkinson’s disease: impact of disease and psychosocial consequences. Mov Disord. 2003;18(11):1250-6. doi:10.1002/mds.10527
  • 15 Thenganatt MA, Jankovic J. Parkinson disease subtypes. JAMA Neurol 2014;71(4):499-504. doi:10.1001/jamaneurol.2013.6233
  • 16 Marras C, Lang A. Parkinson’s disease subtypes: lost in translation? J Neurol Neurosurg Psychiatry. 2013;84(4):409-15. doi:10.1136/jnnp-2012-303455
  • 17 Hindle JV. Ageing, neurodegeneration and Parkinson’s disease. Age Ageing. 2010;39(2):156-61. doi:10.1093/ageing/afp223
  • 18 Wickremaratchi MM, Ben-Shlomo Y, Morris HR. The motor effect of onset on the clinical features of Parkinson’s disease. Eur J Neurol. 2009;16(4):450-6. doi:10.1111/j.1468-1331.2008.02514.x
  • 19 Skodda S, Grönheit W, Schlegel U. Impairment of vowel articulation as a possible marker of disease progression in Parkinson’s disease. PLoS One. 2012;7(2):e32132. doi:10.1371/journal.pone.0032132
  • 20 Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55(3):181-4. doi:10.1136/jnnp.55.3.181
  • 21 American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 2000.
  • 22 The Unified Parkinson’s Disease Scale (UPDRS): status and recommendations. Mov Disord. 2003:18(7):738-50. doi:10.1002/mds.10473
  • 23 Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17(5):427-42. doi:10.1212/WNL.17.5.427
  • 24 Rusz J, Cmejla R, Tykalova T, Ruzickova H, Klempir J, Majerova V. Imprecise vowel articulation as a potential early marker of Parkinson’s disease: effect of speaking task. J Acoustic Soc Am. 2013;134(3):2171-81. doi:10.1121/1.4816541
  • 25 Sapir S, Ramig LO, Spielman JL, Fox C. Formant centralization ratio (FCR): a proposal for a new acoustic measure of dysarthric speech. J Speech Lang Hear Res. 2010;53(1):114-125. doi:10.1044/1092-4388(2009/08-0184)
  • 26 Skodda S, Grönheit W, Mancinelli N, Schlegel U. Progression of voice and speech impairment in the course of Parkinson’s disease: a longitudinal study. Parkinson Dis. 2013;2013:ID389195. doi:10.1155/2013/389195
  • 27 Skodda S, Visser W, Schlegel U. Vowel articulation in Parkinson’s disease. J Voice. 2011;25(4):467-72. doi:10.1016/j.jvoice.20doi:10.01.009
  • 28 Kim Y, Kent RD, Weismer G. An acoustic study of the relationships among neurological disease, dysarthria type, and severity of dysarthria. J Speech Lang Hear Res. 2011;54(2):417-29. doi:10.1044/1092-4388(2010/10-0020)
  • 29 Sapir S, Ramig L, Spielman J, Fox C. Acoustic metrics of vowel articulation in Parkinson’s disease: vowel space area (VSA) Vs. vowel articulation index (VAI). In: Proceedings of the 7th International Workshop on models and analysis of vocal emissions for biomedical applications. Firenze: Firenze University Press; 2011. p. 173-5.
  • 30 Kempster PA, O’Sullivan SS, Holton JL, Revesz T, Lees AJ. Relationships between age and late progression of Parkinson’s disease: a clinico-pathological study. Brain. 2010;133(6):1755-62. doi:10.1093/brain/awq059